GC Genome Ratios and Metrics

Market cap in millions KRW. Fiscal year is January - December.

Millions KRW. Fiscal year is Jan - Dec.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 10, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Market Capitalization	120,146	161,298	-	-	-	-
Enterprise Value	81,387	124,035	-	-	-	-
Last Close Price	5080.00	6820.00	-	-	-	-
PE Ratio	25.56	39.88	-	-	-	-
PS Ratio	3.74	5.12	-	-	-	-
PB Ratio	1.52	2.06	-	-	-	-
P/TBV Ratio	1.53	2.08	-	-	-	-
P/FCF Ratio	91.07	163.66	-	-	-	-
P/OCF Ratio	73.68	124.37	-	-	-	-
EV/Sales Ratio	2.53	3.93	-	-	-	-
EV/EBITDA Ratio	17.24	30.23	-	-	-	-
EV/EBIT Ratio	41.65	100.38	-	-	-	-
EV/FCF Ratio	61.69	125.85	-	-	-	-
Debt / Equity Ratio	0.05	0.05	0.14	0.47	0.40	0.74
Debt / EBITDA Ratio	0.94	0.98	2.35	3.18	-	-
Debt / FCF Ratio	2.95	4.08	94.54	-	-	-
Net Debt / Equity Ratio	-0.49	-0.46	-0.06	0.13	-0.26	-0.61
Net Debt / EBITDA Ratio	-9.30	-8.80	-0.93	0.84	16.39	224.25
Net Debt / FCF Ratio	-29.38	-36.63	-37.60	-0.77	1.25	3.96
Asset Turnover	0.49	0.50	0.62	0.60	0.53	0.44
Inventory Turnover	7.93	10.51	11.96	11.56	14.85	-
Quick Ratio	9.18	17.67	3.74	1.00	2.13	6.26
Current Ratio	9.80	18.59	4.27	1.12	2.32	6.42
Return on Equity (ROE)	8.11%	7.26%	-4.32%	-2.13%	-16.52%	1.56%
Return on Assets (ROA)	1.34%	1.23%	-1.85%	0.22%	-4.43%	-3.13%
Return on Invested Capital (ROIC)	3.10%	3.28%	-4.15%	0.67%	-24.07%	-34.01%
Return on Capital Employed (ROCE)	1.70%	1.50%	-3.30%	0.50%	-8.40%	-5.60%
Earnings Yield	3.80%	2.51%	-	-	-	-
FCF Yield	1.10%	0.61%	-	-	-	-
Buyback Yield / Dilution	-22.85%	-20.29%	0.66%	-13.53%	-0.97%	10.25%